DexCom Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
23.30 Mil |
| Income |
-55.45 Mil |
| Net Profit Margin |
-238.00% |
| Return on Equity |
NA |
| Debt/Equity Ratio |
NA |
|
| Revenue/Share |
0.58 |
| Earnings/Share |
-1.41 |
| Book Value/Share |
-0.20 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
| 1st Qtr | 5.2 | 1.9 | 1.0 |
| 2nd Qtr | 6.8 | 2.0 | 0.9 |
| 3rd Qtr | 7.3 | 1.9 | 1.2 |
| 4th Qtr | NA | 4.1 | 1.5 |
| Total | 19.2 | 9.8 | 4.6 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
| 1st Qtr | -$0.33 | -$0.47 | -$0.39 |
| 2nd Qtr | -$0.33 | -$0.51 | -$0.40 |
| 3rd Qtr | -$0.29 | -$0.53 | -$0.40 |
| 4th Qtr | NA | -$0.45 | -$0.43 |
| Total | -$0.95 | -$1.96 | -$1.62 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 27% | -9% | --- |
| 2nd Qtr | 0% | -9% | -3% |
| 3rd Qtr | 12% | -4% | 0% |
| 4th Qtr | NA | 15% | -8% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | 30% | -21% |
| 2nd Qtr | 35% | -27% |
| 3rd Qtr | 45% | -32% |
| 4th Qtr | NA | -5% |
advertisement